background
influenza
vaccin
wide
recommend
everi
year
protect
individu
influenza
viru
infect
ill
publish
estim
influenza
vaccin
effect
hospit
children
subtrop
region
method
conduct
testneg
yearround
studi
octob
septemb
recruit
children
month
year
age
admit
two
hospit
hong
kong
febril
acut
respiratori
infect
case
test
influenza
b
condit
logist
regress
use
estim
vaccin
effect
compar
influenza
vaccin
histori
trival
influenza
vaccin
tiv
among
patient
test
posit
versu
neg
influenza
adjust
age
sex
match
calendar
week
recruit
result
overal
vaccin
effect
hospit
laboratoryconfirm
influenza
b
estim
ci
estim
vaccin
effect
ci
compar
ci
ci
b
conclus
vaccin
effect
hospit
children
vari
year
year
moder
high
overal
even
area
influenza
activ
throughout
year
influenza
viru
caus
substanti
burden
ill
age
group
regular
epidem
occasion
pandem
children
often
face
highest
risk
infect
epidem
higher
level
persontoperson
contact
therefor
greater
exposur
well
lower
immun
due
fewer
previou
infect
influenza
vaccin
effect
reduc
risk
influenza
viru
infect
ill
hong
kong
children
month
year
age
well
underli
condit
render
increas
risk
complic
influenza
viru
infect
recommend
receiv
influenza
vaccin
year
hong
kong
govern
provid
subsidi
influenza
vaccin
children
month
less
year
children
underli
condit
receiv
free
influenza
vaccin
year
advertis
made
televis
radio
broadcast
poster
public
place
bring
awar
public
northern
hemispher
vaccin
use
hong
kong
influenza
vaccin
effect
vari
year
year
import
continu
monitor
confirm
vaccin
provid
adequ
protect
identifi
factor
affect
test
neg
design
approach
estim
influenza
observ
data
base
recruit
case
acut
respiratori
infect
comparison
vaccin
coverag
among
case
test
posit
influenza
viru
versu
coverag
among
case
test
neg
influenza
viru
design
similar
casecontrol
studi
one
major
differ
absenc
group
patient
prospect
identifi
recruit
specif
control
http
elsevi
ltd
right
reserv
studi
except
testneg
studi
conduct
retrospect
laboratori
result
includ
case
definit
separ
group
patient
neg
laboratori
result
influenza
recruit
provid
assumpt
satisfi
design
thought
allow
unbias
estim
major
testneg
studi
report
literatur
conduct
outpati
set
temper
locat
conduct
systemat
surveil
hospit
burden
influenza
among
children
hong
kong
sinc
use
testneg
approach
estim
influenza
popul
studi
provid
better
estim
sever
outcom
influenza
studi
base
queen
mari
hospit
pamela
youd
nethersol
eastern
hospit
public
hospit
hong
kong
island
hong
kong
acut
paediatr
servic
children
month
year
age
admit
gener
ward
either
hospit
febril
acut
respiratori
infect
defin
fever
measur
c
respiratori
symptom
cough
runni
nose
sore
throat
elig
inclus
studi
children
risk
factor
potenti
sever
respiratori
infect
like
prematur
chronic
lung
diseas
exclud
nasopharyng
aspir
obtain
patient
test
influenza
b
viru
immunofluoresc
cultur
season
influenza
b
viru
addit
rtpcr
influenza
viru
influenza
vaccin
histori
within
month
hospit
elicit
parent
legal
guardian
patient
use
standard
questionnair
administ
research
personnel
studi
period
octob
septemb
studi
protocol
approv
institut
review
board
univers
hong
kong
waiv
need
written
consent
sinc
viral
investig
routin
diagnost
test
carri
part
routin
care
patient
inform
delink
individu
patient
identif
maintain
patient
confidenti
particip
respond
questionnair
voluntari
indic
consent
vaccin
children
receiv
trival
inactiv
influenza
vaccin
tiv
within
month
prior
admiss
regimen
dosag
appropri
age
influenza
vaccin
histori
accord
recommend
advisori
committe
immun
practic
last
dose
week
hospit
children
receiv
dose
tiv
receiv
dose
vaccin
within
week
hospit
categor
unvaccin
first
studi
year
octob
septemb
children
receiv
dose
monoval
vaccin
within
month
least
week
prior
hospit
consid
vaccin
npa
specimen
test
influenza
viru
direct
antigen
detect
direct
immunofluoresc
viru
cultur
recruit
patient
virolog
laboratori
queen
mari
hospit
hong
kong
public
health
laboratori
centr
hong
kong
direct
immunofluoresc
antigen
test
carri
previous
describ
use
imagentm
respiratori
screen
type
reagent
oxoid
eli
ltd
uk
specimen
found
posit
respiratori
screen
pool
reagent
identifi
use
antibodi
reagent
individu
viru
influenza
b
respiratori
syncyti
viru
parainfluenza
viru
type
adenoviru
use
imagen
tm
type
kit
cultur
respiratori
virus
mdck
c
rd
cell
monolay
cultur
tube
inocul
l
nasopharyng
aspirateviru
transport
medium
suspens
viru
isol
carri
previous
describ
addit
pandem
wave
npa
sampl
test
influenza
rtpcr
total
nucleic
acid
l
npa
extract
use
nuclisen
easymag
instrument
biomerieux
netherland
accord
manufactur
instruct
previous
describ
nucleic
acid
recov
l
elut
buffer
kept
c
use
diagnosi
influenza
viru
perform
rtpcr
target
gene
previous
describ
realtim
onestep
rtpcr
assay
use
detect
pandem
viru
use
invitrogen
superscript
iii
platinum
onestep
quantit
kit
sequenc
detect
system
appli
biosystem
foster
citi
ca
usa
briefli
l
elut
rna
amplifi
l
reaction
contain
l
superscript
iii
revers
transcriptaseplatinum
taq
dna
polymeras
invitrogen
l
rox
refer
dye
l
reaction
buffer
nmoll
forward
primer
revers
primer
probe
nmoll
famtgataaagggaaagaagtcctmgb
reaction
first
incub
c
min
follow
c
min
thermal
cycl
cycl
c
c
patient
met
inclus
criteria
consent
particip
includ
studi
use
condit
logist
regress
model
match
calendar
week
account
potenti
bia
due
chang
vaccin
coverag
time
adjust
age
agesquar
allow
nonlinear
effect
age
sex
estim
minu
adjust
condit
odd
ratio
estim
influenza
b
combin
specif
type
subtyp
exclud
patient
posit
typessubtyp
influenza
control
group
estim
overal
four
studi
year
variou
age
strata
overal
estim
estim
season
vaccin
adjust
receipt
monoval
vaccin
sensit
analys
examin
altern
comparison
group
base
detect
nondetect
respiratori
virus
patient
test
neg
influenza
fig
previous
shown
influenza
activ
pediatr
hospit
limit
winter
peak
hong
kong
major
children
year
younger
age
male
femal
although
signific
gender
differ
test
posit
neg
influenza
tabl
testneg
patient
report
receipt
influenza
vaccin
preced
month
compar
patient
test
posit
influenza
b
viru
p
among
patient
month
year
age
report
receipt
influenza
vaccin
preced
month
compar
among
children
year
among
children
year
parent
unabl
recal
exact
date
vaccin
histori
vaccin
given
show
children
receiv
tiv
well
januari
appear
common
practic
hong
kong
differ
place
like
us
main
annual
influenza
vaccin
happen
coupl
month
octob
novemb
fall
patient
test
neg
influenza
recruit
calendar
week
testposit
patient
fig
patient
exclud
estim
patient
remain
analysi
overal
confid
interv
ci
influenza
b
combin
base
report
receipt
season
influenza
vaccin
preced
month
compar
testposit
testneg
patient
b
panneg
patient
includ
patient
test
neg
influenza
viru
also
neg
respiratori
virus
includ
respiratori
syncyti
viru
parainfluenza
viru
type
adenoviru
use
imagentm
type
kit
c
noninfluenza
viru
posit
patient
includ
patient
test
neg
influenza
viru
posit
respiratori
virus
includ
respiratori
syncyti
viru
parainfluenza
viru
type
adenoviru
use
imagentm
type
kit
fig
also
year
high
activ
influenza
virus
throughout
year
season
tiv
includ
new
pandem
viru
separ
monoval
vaccin
use
low
uptak
commun
year
estim
monoval
vaccin
influenza
ci
typesubtypespecif
estim
shown
fig
point
estim
lower
ci
compar
ci
b
ci
year
subtyp
estim
wide
confid
interv
none
admit
children
test
posit
influenza
typesubtyp
report
receipt
tiv
fig
agespecif
estim
shown
fig
point
estim
lower
children
month
year
age
compar
older
children
differ
statist
signific
primari
analysi
assess
compar
testposit
patient
testneg
patient
sensit
analys
similar
compar
testneg
patient
also
neg
respiratori
virus
compar
testneg
patient
posit
noninfluenza
respiratori
virus
tabl
studi
cover
least
period
influenza
activ
hong
kong
includ
emerg
fig
overal
tiv
influenza
hospit
ci
recent
publish
studi
australia
children
present
tertiari
pediatr
hospit
conduct
also
show
ci
howev
subject
recruit
emerg
depart
smaller
proport
inpati
also
exclud
subject
enrol
calcul
overal
monoval
vaccin
studi
ci
somewhat
lower
report
elsewher
time
interv
receipt
monoval
vaccin
hospit
children
test
posit
first
pandem
season
may
adequ
mount
immunolog
respons
contrast
includ
tiv
high
ci
appear
low
studi
could
due
vaccin
mismatch
year
studi
studi
sever
countri
also
show
low
moder
season
adult
children
also
antigen
mismatch
vaccin
howev
circul
strain
hong
kong
match
vaccin
still
poor
one
possibl
explan
epidem
late
peak
septemb
fig
therefor
may
low
due
wane
postvaccin
immun
studi
uk
show
show
wane
intraseason
protect
moder
first
three
month
season
reduc
second
three
month
even
antigen
match
captur
vaccin
histori
within
month
inform
vaccin
within
month
influenza
vaccin
typic
administ
octob
januari
prior
winter
influenza
season
hong
kong
epidem
studi
summer
fall
larg
mismatch
vaccin
strain
find
may
gener
influenza
b
hospit
overal
ci
surprisingli
good
consid
circul
influenza
b
lineag
victoria
yamagata
ratio
largest
influenza
b
epidem
studi
tiv
includ
victoria
lineag
viru
specif
influenza
b
mismatch
season
ci
seen
appear
higher
fig
estim
effect
trival
inactiv
influenza
vaccin
influenza
b
combin
studi
year
overal
estim
adjust
age
age
squar
sex
match
calendar
week
estim
overal
also
adjust
receipt
monoval
vaccin
ci
poor
match
season
accord
metaanalysi
control
trial
tiv
children
nonelderli
adult
studi
also
shown
suboptim
situat
mismatch
season
one
explan
differ
seen
previou
studi
may
sinc
preval
crossprotect
antibodi
function
previou
prime
antigen
relat
strain
subtyp
children
hong
kong
high
influenza
activ
like
prime
influenza
b
lineag
studi
canada
show
adjust
ci
mismatch
influenza
b
adult
children
also
demonstr
crossprotect
quadrival
influenza
vaccin
contain
b
lineag
licens
recommend
use
us
season
multin
studi
quadrival
influenza
vaccin
moderatetosever
pcrconfirm
influenza
recent
publish
surprisingli
moder
sever
influenza
b
diseas
defin
bodi
temperatur
higher
c
otiti
media
lower
respiratori
tract
ill
myositi
enceph
seizur
myocard
ci
season
almost
exclus
victoria
lineag
vaccin
effect
studi
compar
quadrival
trival
vaccin
conduct
determin
whether
theoret
advantag
inclus
strain
b
lineag
could
translat
real
improv
previous
report
increas
risk
noninfluenza
respiratori
viru
infect
among
children
year
age
receiv
influenza
vaccin
impli
estim
testneg
studi
might
vari
depend
choic
comparison
group
therefor
examin
differ
estim
use
altern
comparison
group
find
major
differ
studi
hospit
tabl
major
patient
year
age
younger
similar
observ
also
report
us
children
year
age
seek
ambulatori
care
admit
hospit
first
studi
geograph
site
outsid
area
sharp
peak
influenza
season
winter
unlik
influenza
studi
studi
conduct
year
round
allow
us
captur
influenza
hospit
particularli
relev
area
prolong
multipl
influenza
season
well
influenza
b
epidem
occur
time
year
anoth
strength
studi
includ
match
testposit
patient
testneg
patient
recruit
week
may
particularli
import
influenza
activ
concentr
week
furthermor
shown
result
robust
even
use
differ
criteria
defin
test
neg
group
tabl
viz
influenza
neg
neg
virus
test
posit
virus
one
limit
analysi
use
immunofluoresc
viru
cultur
identifi
respiratori
virus
lead
lack
sensit
identifi
rhinovirus
noninfluenza
virus
eg
human
coronavirus
human
metapneumoviru
direct
immunofluoresc
antigen
test
respiratori
virus
identifi
respiratori
virus
includ
influenza
influenza
rsv
parainfluenza
parainfluenza
parainfluenza
adenoviru
cultur
respiratori
virus
abl
isol
respiratori
virus
lack
sensit
certain
virus
human
metapneumoviru
compar
rtpcr
hmpv
sensit
cultur
unpublish
data
unabl
recov
rhinoviru
type
c
unabl
isol
human
coronavirus
furthermor
relianc
viru
cultur
immunofluoresc
assay
rather
rtpcr
may
led
underdetect
influenzaposit
patient
consequ
underestim
second
limit
vaccin
histori
preced
month
selfreport
may
misclassif
bia
lead
underestim
overestim
overal
mention
collect
data
exact
date
vaccin
also
inform
comorbid
addit
definit
fig
estim
effect
trival
inactiv
influenza
vaccin
influenza
b
combin
age
group
overal
estim
adjust
age
age
squar
sex
match
calendar
week
estim
overal
also
adjust
receipt
monoval
vaccin
vaccin
statu
receiv
vaccin
within
month
hospit
may
fals
bia
toward
higher
set
influenza
season
last
mani
month
given
may
feasibl
vaccin
year
true
late
influenza
season
may
lower
estim
children
vaccin
novemberdecemb
period
recommend
hong
kong
final
definit
vaccin
statu
receiv
vaccin
within
month
hospit
preclud
assess
whole
year
line
practic
annual
influenza
vaccin
conclus
found
influenza
vaccin
effect
prevent
hospit
associ
confirm
influenza
b
viru
infect
children
vaccin
effect
vari
year
correl
vaccin
match
although
impact
mismatch
b
lineag
less
clear
protect
hospit
also
appear
decreas
epidem
happen
late
year
analys
chose
match
testposit
testneg
patient
calendar
week
allow
fairer
estim
given
chang
vaccin
coverag
cours
year
approach
may
particularli
valuabl
subtrop
tropic
set
prolong
influenza
activ
